الفهرس 
Comparison between high dose oxytocin and carbetocin on intraoperative blood loss in cesarean sections at high risk for atonic postpartum hemorrhage
LIST OF CONTENTSOnly 14 pages are availabe for public view
 |  | from | 111 |  |  |
| | | from | 111 | | |
Abstract
Postpartum hemorrhage (PPH) is a life-threatening condition representing one of the leading causes of peripartum maternal death throughout the world. A primary cause of PPH is uterine atony. Two uterotonics, oxytocin and carbetocin are in the Essential Medicines List by the World Health Organization,
Aim and objectives: To compare between effectiveness and safety of carbetocin and oxytocin on intraoperative blood loss in cesarean deliveries at high risk for PPH.
Subjects and methods: This study is randomized clinical trial, was carried out on 100 pregnant women at Obstetrics and Gynecology Emergency Department (Kasr Al-Ainy Hospital – Faculty of Medicine – Cairo University) in the period between May2021 to August 2021.
Results: There was significant difference between both groups regarding additional use of other uterotonic drugs.
Conclusion: Carbetocin appeared to be as effective as oxytocin for prevention of postpartum hemorrhage in patient undergoing elective cesarean section.